- Home
- Companies
- north america
- cardiorespiratory
Refine by
Cardiorespiratory Suppliers In North America
4 companies found
based inWoodcliff Lake, NEW JERSEY (USA)
Eagle is a specialty pharmaceutical company working to advance safe and efficient injectable treatments for patients across oncology, critical care, and orphan diseases. At Eagle, we are committed to developing innovative drugs that result in ...
Indication: Byfavo is a benzodiazepine indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or ...
based inSan Rafael, CALIFORNIA (USA)
Established in 1997, BioMarin is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and ...
ALDURAZYME (laronidase) is indicated for patients with Hurler and Hurler-Scheie forms of mucopolysaccharidosis I (MPS I) and for patients with the Scheie form who have moderate to severe symptoms. The risks and benefits of treating mildly affected ...
based inSaint Paul, MINNESOTA (USA)
Since 1977, we’ve been dedicated to cardiorespiratory health solutions. Headquartered in Saint Paul, Minnesota, USA, MGC Diagnostics Corporation, develops, manufactures and markets non-invasive diagnostic systems for detecting, classifying and ...
People are not square, so why are most body box systems? We took the natural shape of the human body into consideration when we designed the Platinum Elite body plethysmograph system. We know that patients breathe more normally when they are in a ...
based inExport, PENNSYLVANIA (USA)
Circadiance develops, manufactures and markets respiratory products for people with sleep-disordered breathing, who need non-invasive ventilation or who require monitoring. Circadiance is a pioneer in respiratory therapy specializing in positive ...
For Use with SmartMonitor Devices: Synergy Cloud software allows clinicians to remotely monitor infants who are at risk for apneas, bradycardias, or desaturations— reducing the length of stay for newborns in the NICU and making home infant ...